Investment
Features
FeesSafety
Academy
More
Pluang+

Robinhood Chain now supports USDG stablecoin deposits and withdrawals via Aster without KYC.

Protocol Fundamentals
21 Aug 2026
Crypto Briefing
View Source
Bullish
Robinhood Chain now supports USDG stablecoin deposits and withdrawals via Aster without KYC.

Robinhood Chain, a Layer 2 blockchain launched in July 2026, now allows USDG stablecoin deposits and withdrawals through Aster, an on-chain trading platform that requires no KYC. This integration enables users to trade directly from self-custody wallets, maintaining control of private keys and bypassing centralized intermediaries. USDG, backed 1:1 by Paxos and offering up to 7% APY via Robinhood’s Earn product, gains increased utility and liquidity within Robinhood’s ecosystem. This move strengthens USDG's position alongside dominant stablecoins like USDC and USDT by leveraging Robinhood Chain’s native environment.

More News

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital is set to report a fiscal Q1 loss of $0.30 per share on $116.3 million revenue, reflecting ongoing investments in AI and high-performance data centers. The company has expanded its Polaris Forge 1 campus to 250 MW operational capacity...

Company Fundamentals
Bullish
1 hour ago
Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to ...

Analyst Insights
Bullish
2 hours ago
GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's investigational drug Rina-S demonstrated a 45.9% confirmed response rate in a Phase 1/2 trial for platinum-resistant ovarian cancer, with a median response duration of 12.1 months and median progression-free survival of 9.5 months. Despite ser...

Market News
Bullish
3 hours ago
NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

NVIDIA price target raised to $345 on strong AI chip demand and earnings growth.

BNP Paribas Exane raised NVIDIA's price target from $285 to $345 due to strong demand for its AI chips, signaling potential upside of about 45.6% from the current price. NVIDIA shares have gained about 25% in 2026, driven by growth in AI infrastructu...

Analyst Insights
Bullish
4 hours ago
SUI price rises 3.31% in one hour with $270K short liquidations on major exchanges

SUI price rises 3.31% in one hour with $270K short liquidations on major exchanges

SUI (Sui) token price increased by 3.31% within an hour, reaching $1.23 as of 5:52 a.m. ET on October 6. During this period, short liquidations totaled $270,000 across major exchanges Binance, Bybit, and OKX, while no long liquidations occurred. The ...

Technical Signals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App